201 related articles for article (PubMed ID: 33758865)
1. Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Staquicini DI; Tang FHF; Markosian C; Yao VJ; Staquicini FI; Dodero-Rojas E; Contessoto VG; Davis D; O'Brien P; Habib N; Smith TL; Bruiners N; Sidman RL; Gennaro ML; Lattime EC; Libutti SK; Whitford PC; Burley SK; Onuchic JN; Arap W; Pasqualini R
bioRxiv; 2021 Mar; ():. PubMed ID: 33758865
[TBL] [Abstract][Full Text] [Related]
2. Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Staquicini DI; Tang FHF; Markosian C; Yao VJ; Staquicini FI; Dodero-Rojas E; Contessoto VG; Davis D; O'Brien P; Habib N; Smith TL; Bruiners N; Sidman RL; Gennaro ML; Lattime EC; Libutti SK; Whitford PC; Burley SK; Onuchic JN; Arap W; Pasqualini R
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34234013
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
4. Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
Suwan K; Yata T; Waramit S; Przystal JM; Stoneham CA; Bentayebi K; Asavarut P; Chongchai A; Pothachareon P; Lee KY; Topanurak S; Smith TL; Gelovani JG; Sidman RL; Pasqualini R; Arap W; Hajitou A
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18571-18577. PubMed ID: 31375630
[TBL] [Abstract][Full Text] [Related]
5. The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.
Tsafa E; Al-Bahrani M; Bentayebi K; Przystal J; Suwan K; Hajitou A
Oncotarget; 2016 Aug; 7(32):52135-52149. PubMed ID: 27437775
[TBL] [Abstract][Full Text] [Related]
6. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylation and DNA methylation improves gene expression mediated by the adeno-associated virus/phage in cancer cells.
Kia A; Yata T; Hajji N; Hajitou A
Viruses; 2013 Oct; 5(10):2561-72. PubMed ID: 24153059
[TBL] [Abstract][Full Text] [Related]
8. AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.
Smith TL; Yuan Z; Cardó-Vila M; Sanchez Claros C; Adem A; Cui MH; Branch CA; Gelovani JG; Libutti SK; Sidman RL; Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):2466-71. PubMed ID: 26884209
[TBL] [Abstract][Full Text] [Related]
9. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
10. Design and construction of targeted AAVP vectors for mammalian cell transduction.
Hajitou A; Rangel R; Trepel M; Soghomonyan S; Gelovani JG; Alauddin MM; Pasqualini R; Arap W
Nat Protoc; 2007; 2(3):523-31. PubMed ID: 17406616
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage.
Przystal JM; Umukoro E; Stoneham CA; Yata T; O'Neill K; Syed N; Hajitou A
Mol Oncol; 2013 Feb; 7(1):55-66. PubMed ID: 22951279
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
13. The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine.
Ul Haq I; Krukiewicz K; Yahya G; Haq MU; Maryam S; Mosbah RA; Saber S; Alrouji M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675046
[TBL] [Abstract][Full Text] [Related]
14. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector.
Hajitou A
Adv Genet; 2010; 69():65-82. PubMed ID: 20807602
[TBL] [Abstract][Full Text] [Related]
15. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Elife; 2020 Oct; 9():. PubMed ID: 33112236
[TBL] [Abstract][Full Text] [Related]
16. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
[TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D
Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
[TBL] [Abstract][Full Text] [Related]
20. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
